System for classifying antibody concentration against severe acute respiratory syndrome coronavirus 2 S1 spike antigen with automatic quick response generation for integration with health passports

Abstract

Aim: After the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and the realization of mass vaccination against the virus, the availability of a reliable, rapid, and easy-to-use system for registering the individual anti-S1 antibody titer could facilitate the personalized assessment of the need for booster vaccine doses and the reduction of social distancing and other measures.

Methods: The biosensor system is based on immobilized engineered SK-N-SH neuroblastoma cells, bearing the S1 protein, and it can detect immunoglobulin G (IgG) antibodies against the SARS-CoV-2 S1 spike antigen. A disposable electrode strip bearing the engineered mammalian cells is connected to a customized read-out potentiometric device with real-time data transmission to a wireless fidelity (WiFi)-connected smartphone. Blood samples from past-infected individuals and individuals vaccinated against SARS-CoV-2 were used for validation.

Results: In the present study, a smartphone application (app), capable of analyzing data regarding the levels of anti-S1 antibodies in blood is introduced. The app works in conjunction with a portable, ultra-rapid, and sensitive biosensor transmitting real-time measurements to the smartphone. Both historical and current individual data can be encoded by using the app, resulting in a widely accepted quick response (QR) code, which can then be constantly updated to match a person’s status.

Conclusions: This novel system could be utilized for the eventual development of a coronavirus disease 2019 (COVID-19) electronic passport, which could be further employed to improve the population-wide, cross-country surveillance of vaccination efficiency, as well as facilitate the implementation of cross-border digital health services in a user-friendly and secure way.

Keywords

Antibody screening / biosensor / health passport / quick response code / severe acute respiratory syndrome coronavirus 2 / smartphone / surveillance / vaccination

References

[1] Hall MA, Studdert DM. “Vaccine passport” certification - policy and ethical considerations. N Engl J Med. 2021; 385:e32.

[2] Gostin LO, Cohen IG, Shaw J. Digital health passes in the age of COVID-19: Are “vaccine passports” lawful and ethical? JAMA. 2021; 325:1933-4.

[3] Voigt K. COVID-19 vaccination passports: Are they a threat to equality? Public Health Ethics. 2022; 15:51-63.

[4] Khan ML, Malik A, Ruhi U, Al-Busaidi A. Conflicting attitudes: analyzing social media data to understand the early discourse on COVID-19 passports. Technol Soc. 2022; 68:101830.

[5] Voo TC, Reis AA, Thomé B, Ho CW, Tam CC, Kelly-Cirino C, et al. Immunity certification for COVID-19: ethical considerations. Bull World Health Organ. 2021; 99:155-61.

[6] Burbelo PD, Keller JM, Iadarola MJ. Comprehensive antibody profiles as personalized indicators of health and disease. Discov Med. 2017; 24:161-8.

[7] Bradley BT, Bryan A, Fink SL, Goecker EA, Roychoudhury P, Huang ML, et al. Anti-SARS-CoV-2 antibody levels measured by the AdviseDx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity. J Clin Microbiol. 2021; 59:e0098921.

[8] Bansal A, Garg C, Padappayil RP. Optimizing the implementation of COVID-19 “immunity certificates” using blockchain. J Med Syst. 2020; 44:140.

[9] Eisenstadt M, Ramachandran M, Chowdhury N, Third A, Domingue J. COVID-19 antibody test/vaccination certification: There’s an app for that. IEEE Open J Eng Med Biol. 2020; 1:148-55.

[10] Bramstedt KA. Antibodies as currency: COVID-19’s golden passport. J Bioeth Inq. 2020; 17:687-9.

[11] Liu Y, Yang J, Liu M. Recognition of QR code with mobile phones. In: 2008 Chinese Control and Decision Conference. Chinese Control and Decision Conference, CCDC; 2008 Jul 2-4; Yantai, Shandong. IEEE; 2008. pp. 203-6.

[12] Tiwari S. An introduction to QR code technology. In: 2016 International Conference on Information Technology (ICIT). International Conference on Information Technology (ICIT); 2016 Dec 22-24; Bhubaneswar, India. IEEE;2016. pp. 39-44.

[13] Dube S, Ndlovu S, Nyathi T, Sibanda K. QR code based patient medical health records transmission: Zimbabwean case. In: Cohen E, editor. Proceedings of Informing Science & IT Education Conference (InSITE) 2015. Informing Science & IT Education Conference (InSITE) 2015; Bulawayo, Zimbabwe. 2015. pp. 521-30.

[14] Uzun V, Bilgin S. Evaluation and implementation of QR code identity tag system for healthcare in Turkey. Springerplus. 2016; 5:1454.

[15] Wahsheh HAM, Al-Zahrani MS. Secure and usable QR codes for healthcare systems: the case of Covid-19 pandemic. In: 2021 12th International Conference on Information and Communication Systems (ICICS). International Conference on Information and Communication Systems (ICICS); 2021 May 24-26; Valencia, Spain. IEEE; 2021. pp. 324-9.

[16] Sharara S, Radia S. Quick response (QR) codes for patient information delivery: a digital innovation during the coronavirus pandemic. J Orthod. 2022; 49:89-97.

[17] Mavrikou S, Papaioannou GM, Tsekouras V, Hatziagapiou K, Tatsi EB, Filippatos F, et al. Ultra-fast and sensitive screening for antibodies against the SARS-CoV-2 S1 spike antigen with a portable bioelectric biosensor. Chemosensors. 2022; 10:254.

[18] Majchrzak TA, Biørn-Hansen A, Grønli TM. Comprehensive analysis of innovative cross-platform app development frameworks. In: Proceedings of the 50th Hawaii International Conference on System Sciences. Hawaii International Conference on System Sciences; 2017 Jan 4-7; Hawaii, USA.2017. pp. 6162-71.

[19] Novac OC, Novac CM, Ciora B, Gordan CE, Gordan MI, Bujdosó G. The rise of mobile development: a comparison between Ionic and Flutter. In: 2022 14th International Conference on Electronics, Computers and Artificial Intelligence (ECAI). International Conference on Electronics, Computers and Artificial Intelligence (ECAI); 2022 Jun 30-Jul 1; Ploiesti, Romania. IEEE; 2022. pp. 1-10.

[20] The mobile SDK for the web. Version 6.20.3 [software]. [cited 2023 Feb 20]. Available from:https://ionicframework.com

[21] Coronavirus disease (COVID-19): herd immunity, lockdowns and COVID-19 [Internet]. WHO; c2024 [cited 2023 Feb 20]. Available from:https://www.who.int/news-room/questions-and-answers/item/herd-immunity-lockdowns-and-covid-19

[22] De Giorgi V, West KA, Henning AN, Chen LN, Holbrook MR, Gross R, et al. Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection. J Infect Dis. 2021; 224:1294-304.

[23] Harvey RA, Rassen JA, Kabelac CA, Turenne W, Leonard S, Klesh R, et al. Association of SARS-CoV-2 seropositive antibody test with risk of future infection. JAMA Intern Med. 2021; 181:672-9.

[24] Kang CK, Kim M, Lee S, Kim G, Choe PG, Park WB, et al. Longitudinal analysis of human memory T-cell response according to the severity of illness up to 8 months after severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021; 224:39-48. Erratum in: J Infect Dis. 2023;227:1113-4.

[25] REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL pursuant to article 16(3) of regulation (EU) 2021/953 of the European Parliament and of the council on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU digital COVID certificate) to facilitate free movement during the COVID-19 pandemic [Internet]. [cited2022 Dec 22]. Available from:https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A52022DC0753&qid=1677674646886&print=true